Schall Thomas J.
SEC insider (Form 3/4/5 filer). CIK 0001423084. Director at Immuneering Corp (IMRX). 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 11, 2026. Located in CAMBRIDGE, MA.
Companies Schall Thomas J. has filed insider reports for
- Immuneering Corp (IMRX): Director
Schall Thomas J.
CIK: 0001423084
Transaction Breakdown
Open Market Buys (P)3 (60.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (40.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
IMRX
Immuneering Corp
Director
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 11, 2026IMRX
Immuneering Corp
AwardDirectStock Option
33.4K shares- - Jan 15, 2026IMRX
Immuneering Corp
PurchaseDirect21.6K shares at avg. $4.67$101K - Jun 27, 2025IMRX
Immuneering Corp
PurchaseDirect9.5K shares at avg. $3.66$35K - Jun 17, 2025IMRX
Immuneering Corp
PurchaseDirect40.5K shares at avg. $2.21$89K - Jun 13, 2025IMRX
Immuneering Corp
AwardDirectStock Option
33.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 11, 2026 | IMRX Immuneering Corp | Award Stock Option | 33,350 | - | - | Direct |
| Jan 15, 2026 | IMRX Immuneering Corp | Purchase | 21,645 | $4.67 | $101,041 | Direct |
| Jun 27, 2025 | IMRX Immuneering Corp | Purchase | 9,500 | $3.66 | $34,788 | Direct |
| Jun 17, 2025 | IMRX Immuneering Corp | Purchase | 40,485 | $2.21 | $89,278 | Direct |
| Jun 13, 2025 | IMRX Immuneering Corp | Award Stock Option | 33,350 | - | - | Direct |
1-5 of 5 transactions